Terms: = Uterine cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Clinical Outcome
14 results:
1. Lymph-vascular Space Involvement and/or p53 Overexpression Correlated With the clinical outcome of Early-stage Endometrial cancer Patients Treated With Adjuvant Vaginal Brachytherapy.
Laliscia C; Gadducci A; Coccia N; Mattioni R; Fuentes T; Caretto M; Pistolesi S; Puccini P; Perrone F; Morganti R; Paiar F
Anticancer Res; 2023 Jan; 43(1):149-156. PubMed ID: 36585177
[TBL] [Abstract] [Full Text] [Related]
2. Image-Guided Brachytherapy a Comparison Between 192Ir and 60Co Sources in Carcinoma uterine Cervix.
Sinnatamby M; Kandasamy S; Karunanidhi G; Neelakandan V; Ramapandian S; Kannan M; Sampath E
Gulf J Oncolog; 2022 Jan; 1(38):7-14. PubMed ID: 35156639
[TBL] [Abstract] [Full Text] [Related]
3. Long-term clinical outcome and dosimetric comparison of tandem and ring versus tandem and ovoids intracavitary application in cervical cancer.
Atasever Akkas E; Altundag MB
J BUON; 2021; 26(3):698-706. PubMed ID: 34268923
[TBL] [Abstract] [Full Text] [Related]
4. Treatment outcome of the Combination Therapy of High-dose rate Intracavitary Brachytherapy and Intensity-modulated Radiation Therapy With Central-shielding for Cervical cancer.
Mukai Y; Minagawa Y; Inoue H; Sato A; Matsui K; Fukuda T; Onuma K; Hongo H; Shirata R; Nagata H; Hashimoto H; Inoue T; Hata M; Omura M
In Vivo; 2020; 34(6):3387-3398. PubMed ID: 33144446
[TBL] [Abstract] [Full Text] [Related]
5. CT based three dimensional dose-volume evaluations for high-dose rate intracavitary brachytherapy for cervical cancer.
Murakami N; Kasamatsu T; Wakita A; Nakamura S; Okamoto H; Inaba K; Morota M; Ito Y; Sumi M; Itami J
BMC Cancer; 2014 Jun; 14():447. PubMed ID: 24938757
[TBL] [Abstract] [Full Text] [Related]
6. clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer.
Pötter R; Georg P; Dimopoulos JC; Grimm M; Berger D; Nesvacil N; Georg D; Schmid MP; Reinthaller A; Sturdza A; Kirisits C
Radiother Oncol; 2011 Jul; 100(1):116-23. PubMed ID: 21821305
[TBL] [Abstract] [Full Text] [Related]
7. clinical outcome with adjuvant treatment of endometrial carcinoma using intensity-modulated radiation therapy.
Beriwal S; Jain SK; Heron DE; Kim H; Gerszten K; Edwards RP; Kelley JL
Gynecol Oncol; 2006 Aug; 102(2):195-9. PubMed ID: 16647748
[TBL] [Abstract] [Full Text] [Related]
8. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
[TBL] [Abstract] [Full Text] [Related]
9. Surgically (laparotomy/laparoscopy) guided placement of high dose rate interstitial irradiation catheters (LG-hdrT): technique and outcome.
Orr JW; Dosoretz DD; Mahoney D; Roland PY; Kelly FJ; Blitzer P; Nakfoor B; Katin M; Rubenstein J; Boothby RR
Gynecol Oncol; 2006 Jan; 100(1):145-8. PubMed ID: 16249021
[TBL] [Abstract] [Full Text] [Related]
10. High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer.
Kucera H; Pötter R; Knocke TH; Baldass M; Kucera E
Wien Klin Wochenschr; 2001 Jan; 113(1-2):58-62. PubMed ID: 11233470
[TBL] [Abstract] [Full Text] [Related]
11. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix.
Nag S; Erickson B; Thomadsen B; Orton C; Demanes JD; Petereit D
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):201-11. PubMed ID: 10924990
[TBL] [Abstract] [Full Text] [Related]
12. A simple method of obtaining equivalent doses for use in hdr brachytherapy.
Nag S; Gupta N
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):507-13. PubMed ID: 10661360
[TBL] [Abstract] [Full Text] [Related]
13. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
Petereit DG; Sarkaria JN; Potter DM; Schink JC
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
[TBL] [Abstract] [Full Text] [Related]
14. High dose rate transperineal interstitial brachytherapy for cervical cancer: high pelvic control and low complication rates.
Demanes DJ; Rodriguez RR; Bendre DD; Ewing TL
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):105-12. PubMed ID: 10477013
[TBL] [Abstract] [Full Text] [Related]
